FLNA

Filana Therapeutics, Inc.

NasdaqCMUSDEQUITY DELAYED

0.95

▲ 0.01 (1.24%)

MARKET · —

Price

Open

0.94

Prev close

0.94

Day high

0.96

Day low

0.94

Volume

105.80K

Market cap

—

P/E (TTM)

—

52W range

0.85 – 4.98

Trailing performance

Price return · vs SPY

Returnvs SPY

+5.49% +6.9%

+3.23% -0.5%

-25.58% -28.7%

-54.93% -66.0%

YTD

-51.52% -63.8%

-55.14% -75.1%

-94.38% -168.6%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.94

+1.62% from price

SMA 20

0.95

+1.27% from price

SMA 50

1.07

-10.51% from price

SMA 100

1.28

-25.37% from price

SMA 200

1.83

-47.42% from price

EMA 12

0.95

+0.93% from price

EMA 26

0.98

-3.07% from price

EMA 50

1.08

-11.60% from price

RSI (14)

46.8

Neutral

MACD (12,26,9)

-0.04

Hist 0.01

ATR (14)

0.06

6.32% of price

Realised vol 30D

62.8%

Annualised

Bollinger upper

1.04

20, 2σ

Bollinger lower

0.85

20, 2σ

50 / 200 cross

Death

1.07 vs 1.83

Trend bias

Below 200

-47.42%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.98

More volatile than market

Correlation to SPY

0.28

Largely independent

Realised vol 30D

62.8%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-81.2%

Peak to trough

Max drawdown 5Y

-99.3%

Peak to trough

ATR 14

0.06

6.32% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 0.95

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

FLNA · links out to the publisher

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update GlobeNewswire · 24d ago Data I/O And 2 Other Promising Penny Stocks To Watch Simply Wall St. · 85d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.